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OBJECTIVES The objective of this study was to identify the factors associated with the development of
depressive symptoms in outpatients with heart failure (HF).
BACKGROUND Depression is common in patients with HF and has been linked to adverse outcomes.
METHODS This was a multicenter prospective cohort study of outpatients with HF and ejection fraction
0.40. Patients were evaluated at baseline and one year with a Medical Outcomes
Study-Depression questionnaire, a Kansas City Cardiomyopathy Questionnaire (KCCQ),
and a full clinical evaluation including patients’ social and economic status.
RESULTS Of 245 patients without depressive symptoms at baseline, 52 (21.2%) developed depressive
symptoms one year later. In multivariable analysis, living alone, alcohol abuse, perception of
medical care as being a substantial economic burden, and health status as measured by the
KCCQ were independent predictors of developing depressive symptoms. For patients
without these factors, 7.9% developed depression by one year. When one factor was present,
the one-year incidence was 15.5%, when two were present the incidence was 36.2%, and when
three were present the incidence was 69.2%. There was a graded relationship between poorer
health status and increased risk of developing depression (p 0.001 for trend). No traditional
clinical factors or measures of disease severity were significantly associated with the
development of depression.
CONCLUSIONS Social factors and health status are predictive of the development of depression in outpatients
with HF. Clinicians should be aware of which patients are at risk for the development of
depression so that these patients may be targeted for screening and potentially for
psychosocial intervention. (J Am Coll Cardiol 2004;44:2333–8) © 2004 by the American
ublished by Elsevier Inc. doi:10.1016/j.jacc.2004.09.034College of Cardiology Foundation
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cepression is a chronic disease that is associated with
imitations in physical and social functioning equal to or
reater than those of other common chronic diseases (1) and
s associated with increased mortality (2). Depression is
ore common in patients with cardiovascular disease than
n the general population, particularly in patients with heart
ailure (HF) (3–6). Furthermore, depressive symptoms in
atients with HF are strongly associated with a decline in
ealth status (7) and an increase in the risk of hospitaliza-
ion and death (6,8).
Such data suggest that reducing the burden of coincident
epression in patients with HF can improve their health.
ne possible intervention is to screen patients with HF for
epression followed by pharmacologic treatment of those
ound to be depressed. Yet, even among those HF patients
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ccepted September 6, 2004.ho are not depressed, it would be valuable to identify those
atients at elevated risk for developing depression. Identi-
ying such patients could suggest the need for an interven-
ion to reduce the incidence of depression. Previous studies
upport the notion that depression prevention programs can
e effective (9) and are consistent with the Institute of
edicine position that one of the critical changes necessary
or transforming American healthcare is for “the system [to]
nticipate patient needs, rather than simply react to events”
10). In order to best target depression screening and
epression prevention interventions, the factors associated
ith the onset of depression in patients with HF must be
stablished. To date, the risk factors for developing depres-
ion in patients with HF have not been described.
The objective of this study was to identify the sociode-
ographic and clinical factors associated with the onset of
epressive symptoms in outpatients with HF.
ETHODS
tudy population. All subjects were enrolled in the Kansas
ity Cardiomyopathy Questionnaire (KCCQ) Interpret-
bility Study. The KCCQ Interpretability Study (11) was
onducted by investigators in the Cardiovascular Outcomes
esearch Consortium (Appendix) at 14 outpatient clinics
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nclusion if they had an HF diagnosis in their medical
ecord or had been hospitalized for HF during the previous
hree years, had a left ventricular ejection fraction 0.40,
nd were at least 30 years of age.
Patients were eligible for this analysis if they did not
ave significant depressive symptoms at baseline, defined
s a Medical Outcomes Study-Depression questionnaire
MOS-D) score of 0.06. The MOS-D (12) is an eight-
tem screening instrument previously used in case-finding
tudies of depression and was selected for the current study
ecause it does not assess somatic symptoms that are
ommon in HF. A cutoff of 0.06 has an approximate
ensitivity of 85% and specificity of 75% for a diagnosis of
ajor depressive disorder (13). Of the 371 patients in the
arent study meeting this criterion, 126 did not have
ne-year follow-up MOS-D data: 35 (9.4%) died, 22
5.9%) refused to complete the instrument, 18 (4.8%) had
ncomplete data, and 51 (13.7%) were lost to follow-up. The
emaining 245 patients form the analytic cohort for this
tudy. Eligible patients with incomplete one-year follow-up
ata were more likely to be black (48% vs. 21%, p  0.001),
ess likely to have a history of depression requiring treatment
1.2% vs. 9.4%, p  0.01), and more likely to have a history
f alcohol abuse. There were no differences in age, gender,
ody mass index, insurance status, smoking, diabetes, living
lone, self-reported difficulty affording healthcare, New
ork Heart Association functional class, ejection fraction,
-type natriuretic peptide level, 6-min walking distance,
CCQ overall summary score, or baseline MOS-D score.
ata collection. At baseline, all patients completed a
tandardized history that included questions about social
nd economic factors and underwent a physical examina-
ion, a 6-min walking test, and a survey battery that
ncluded the MOS-D and the KCCQ (14). The KCCQ is
23-item disease-specific health status instrument for
atients with HF that measures symptoms, physical func-
ioning, social functioning, self-efficacy, and quality of life.
hese individual domains can be summarized into an
verall summary score with a range from 0 to 100, with
igher scores indicating better health status. A previous
nvestigation (11) has defined a clinically significant change
s being 5 points. As previously reported (7), 30.2% of
atients had MOS-D scores consistent with depression.
Patients were contacted by telephone one year after
heir baseline enrollment to complete both the MOS-D
nd the KCCQ. A minimum of 10 attempts were made
Abbreviations and Acronyms
HF  heart failure
KCCQ  Kansas City Cardiomyopathy Questionnaire
MOS-D  Medical Outcomes Study-Depression
questionnaireo contact patients and, if all attempts were unsuccessful, squestionnaire packet was sent. A second mailing was
ent if the patient did not return his or her initial packet.
f there was no reply to the second mailing, the patient
as assumed to be lost to follow-up. Institutional Review
oard approval at each site was secured before study
mplementation, and all patients supplied written in-
ormed consent.
tatistical analysis. We compared baseline demographic
nd clinical variables between subjects who did and did not
evelop depression over the one year of follow-up (i.e.,
etween patients whose follow-up MOS-D score was
0.06 vs. 0.06). Chi-squared tests were used for categor-
cal variables and the Student t test was used for continuous
ariables.
The univariate association between each of the candidate
redictor variables (those listed in Table 1) and the outcome
ariable (depression at one year as indicated by an MOS-D
core 0.06) was determined using simple logistic regres-
ion. Then multiple logistic regression was utilized to define
he independent association between the candidate predic-
or variables and one-year depression status. The multiva-
iable model was built by applying backward elimination to
hose predictor variables that had a univariate p value0.15
nd retaining those variables with p  0.05 in the final
odel. A c-index was calculated to evaluate model discrim-
nation, and the Hosmer-Lemeshow test was applied to
valuate model calibration.
To better define the relationship between baseline health
tatus and subsequent depressive symptom burden, we
ompared the incidence of depression for patients in 25-
oint increments of KCCQ overall score using the
ochran-Armitage test. We also calculated the incidence of
epression by the number of risk factors present.
All analyses were conducted using SAS (SAS Institute,
ary, North Carolina) v8.2 software.
ESULTS
f the 245 patients without depressive symptoms at base-
ine, 52 (21.2%) had developed significant depressive symp-
oms at follow-up and 193 had not.
Table 1 compares the characteristics of those subjects
ith and those without a significant burden of depressive
ymptoms at one-year follow-up. Patients who developed
epressive symptoms were nearly twice as likely to live alone
40.4% vs. 22.9%, p  0.015), were more likely to report
edical care as representing a somewhat to severe economic
urden for them (59.6% vs. 34.3%, p  0.003), and were
ore likely to have a history of alcohol abuse (23.1% vs.
1.4%, p  0.013). Mean KCCQ summary scores (59.7 
3.1 vs. 71.1  20.4, p  0.001) were significantly worse in
hose who developed significant depressive symptoms.
here was a graded relationship between baseline KCCQ
verall summary score and the development of depressive
ymptoms at one year (Fig. 1).
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December 21, 2004:2333–8 Predicting Depression in Heart FailureAmong the markers of HF disease severity at baseline,
ew York Heart Association functional class, exercise
apacity by the 6-min walking test, ejection fraction, pres-
able 1. Comparison of Baseline Characteristics Between Those
ith and Those Without Significant Depressive Symptoms at
ne Year
Depressed
at 1 Year
(n  52)
Not
Depressed
at 1 Year
(n  193)
p
Value
ge (yrs) 60.5  11.3 63.1  12.5 0.186
ender (% female) 25.0 25.4 0.954
ace (% white) 65.4 75.0 0.166
urrently married (%) 44.2 57.3 0.321
iving alone (%) 40.4 22.9 0.015
ducational level (%) 0.631
High school or less 53.8 44.3
Some college 26.9 34.9
College 11.5 13.5
Postgraduate 7.7 7.3
mployment (%) 0.822
Full-time 15.7 16.2
Part-time 9.8 11.0
None 74.5 72.8
nnual income (%) 0.46
$10,000 20.8 20.2
$10,000–29,999 52.1 39.9
$30,000–49,999 12.5 23.5
$50,000–69,999 6.3 7.7
$70,000 8.3 8.7
ealth insurance (%) 75.0 85.0 0.105
conomic burden of medical care (%) 0.003
Severe 15.4 7.4
Moderate 11.5 13.7
Somewhat 32.7 13.2
A little 13.5 21.6
None 26.9 44.2
ccess to medical care (%) 0.348
Extremely difficult 2.0 0.5
Moderately difficult 2.0 3.6
Somewhat difficult 3.9 5.7
Not very difficult 47.1 33.9
No difficulty 45.1 56.3
schemic heart disease (%) 56.0 53.7 0.774
istory of hypertension (%) 65.4 52.3 0.093
hronic lung disease (%) 25.0 19.7 0.402
istory of treated depression (%) 9.6 9.3 1.000
istory of smoking (%) 59.6 59.6 0.999
lcohol abuse (%) 23.1 11.4 0.031
iabetes (%) 44.2 30.6 0.064
YHA functional class (%) 0.268
I 7.7 16.6
II 44.2 47.2
III 44.2 34.2
IV 3.8 2.1
trial fibrillation (%) 25.0 33.7 0.233
-min walk (ft) 975.6  398 1019  396 0.504
jection fraction (%) 24.1  7.8 25.4  8.6 0.316
NP (pg/ml) 315  342 376  366 0.393
CCQ summary score 59.7  23.1 71.1  20.4 0.001
NP  brain natriuretic peptide; KCCQ  Kansas City Cardiomyopathy Question-
aire; NYHA  New York Heart Association.nce of atrial fibrillation, and B-type natriuretic peptide cevels did not differ between the groups. Furthermore, there
as no difference between the groups with regard to a
istory of treated depression. Finally, there were no signif-
cant differences in baseline use of cardiovascular medica-
ions between the two groups.
By multivariable logistic regression analysis, living alone,
conomic burden associated with the costs of medical care,
lcohol abuse, and baseline KCCQ overall summary score
50 were all independent predictors of the development of
epressive symptoms (Table 2). The resulting model had a
-statistic of 0.744, indicating moderately good discrimina-
ive ability. The Hosmer-Lemeshow statistic for the model
as 7.18 (p  0.517), indicating good fit for the model
cross the range of predicted probabilities.
For patients who had none of the four risk factors, there
as a 7.9% chance of having significant depressive symp-
oms at one year. The incidence of significant depressive
ymptoms approximately doubled with each additional risk
actor (Fig. 2). For those with one, two, and three risk
actors, the incidence of significant depressive symptoms at
ne year was 15.5%, 36.2%, and 69.2%, respectively. No
atient had all four risk factors.
Because 35% of the patients with MOS-D scores 0.06
t baseline had scores 0.06 at follow-up, we investigated
he possibility that random fluctuation of the scores influ-
nced our results by constructing a second logistic regression
odel. This model included all 350 patients with baseline
nd follow-up MOS-D scores, and included baseline
OS-D score as a covariate, in addition to other sociode-
ographic, clinical, and health status factors. Estimated
ffects are thus adjusted for regression to the mean. Because
e were specifically interested in predictors of developing
epressive symptoms, we modeled effects for patients with
OS-D scores 0.06 separately from those with scores
0.06. The results of this model appear in Table 3. These
esults are consistent with those of the prior model. There is
ttenuation in the odds ratio associated with the KCCQ
core from 1.61 to 1.22. Nonetheless, KCCQ score retains
significant association with 1-year depression after ac-
igure 1. Incidence of depressive symptoms at one year by baseline Kansas
ity Cardiomyopathy Questionnaire (KCCQ) score.ounting for baseline depression score.
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Predicting Depression in Heart Failure December 21, 2004:2333–8ISCUSSION
he objective of this study was to identify the factors
ssociated with the development of depression among
utpatients with HF. We found four independent predic-
ors of the development of depressive symptoms: living
lone, alcohol abuse, financial burden from medical care,
nd worse baseline HF-specific health status. A sequential
oubling of risk with each additional risk factor was ob-
erved, resulting in a range of risk for developing depression
ver one year from 7.9% for patients without any of the four
isk factors to 69.2% for patients with three of the four risk
actors (no patient had all four risk factors).
To our knowledge, this is the first study to evaluate
redictors of the onset of depression in patients with HF.
tudies in post-myocardial infarction patients have found
ow social support, impaired functional status, and higher
verall burden of illness to be predictive of depression
15,16). Studies in general populations have found female
ender, divorce or separation, unemployment, low educa-
ional attainment, and low income to be significant risk
actors (17,18). Several of these findings echo the findings of
ur study. However, we found that living alone increased
he risk of depression in HF, whereas previous studies in
ther populations did not. Also in contrast to previous
tudies, we did not find female gender to be associated with
he development of depressive symptoms. Finally, the re-
ults of the current study with regard to the relationship
etween depression and alcohol consumption are supported
y previous studies. In a meta-analysis of eight studies,
artka et al. (19) documented a clear quantitative relation-
able 2. Summary Statistics for Multivariable Logistic Regression
Variable Beta
iving alone 0.972
conomic burden 1.106
lcohol abuse 0.9725
CCQ overall score (per 10 points lower score) 0.0223
ntercept 0.889
I  confidence interval; KCCQ  Kansas City Cardiomyopathy Questionnaire.
igure 2. Incidence of depressive symptoms by number of risk factors. The
isk factors are the four significant predictors from the multivariable logistic
egression model (living alone, significant economic present associated withm
he costs of medical care, alcohol abuse, and overall Kansas City Cardio-
yopathy Questionnaire score 50). No patient had all four risk factors.hip between alcohol consumption and subsequent depres-
ion.
The identification of HF patients who are at risk for the
evelopment of depression is important because of the
revalence of depression and the association between de-
ression and adverse outcomes in patients with HF. Ap-
roximately 30% of patients with HF, including both
npatients and outpatients, have significant depressive
ymptoms (3–8). Furthermore, depressed HF patients are at
ncreased risk for mortality, HF hospitalization, and wors-
ning of HF symptoms, functional status, and quality of life
6–8). Knowing the risk factors for the development of
epression, as delineated in this study, may facilitate the
ecognition and treatment of depressed HF patients.
There are several implications of this study. First, depres-
ion screening may be warranted for all patients with HF,
ecause even among patients without any of the risk factors,
bout 8% developed depression over one year. However, it
ay be most critical to screen for depression among those
F patients who have any of the risk factors identified in
his study. This screening should probably be serial in nature
i.e., repeated over time) because of the markedly elevated
isk for the development of depression in these patients.
here are several well-validated and easy-to-use depression
creening instruments, such as the Patient Health Ques-
ionnaire, that can rapidly identify patients with significant
epressive symptoms who may benefit from treatment
20–22). Furthermore, patients with the depression risk
actors identified in this study may be targets for psycho-
ocial interventions, such as case management, social worker
valuation, cognitive therapy for social isolation, or alcohol
buse intervention (9). Future studies should be conducted
o evaluate whether targeted psychosocial intervention for
hese patients can reduce the incidence of depression and
mprove outcomes.
The results of this study also support the use of the
CCQ in evaluating patients with HF. Health status
easures have been shown to predict mortality and cardiac
vents in cardiovascular populations, including HF (5,23–
6). The KCCQ scores have previously been associated with
ubsequent mortality and hospitalization in patients with
F (27). In this study, KCCQ score was one of four
ndependent risk factors for the development of depression
mong outpatients with HF. Therefore, assessing the health
tatus of HF patients using an instrument like the KCCQ
del of Predictors of Depressive Symptoms at One Year
Wald
hi-Squared p Value Odds Ratio 95% CI
6.75 0.009 2.64 1.27–5.54
9.74 0.002 3.02 1.52–6.14
5.02 0.025 2.64 1.11–6.16
7.82 0.005 1.61 1.16–2.27Mo
Cay aid in identification of patients at risk for a wide range
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December 21, 2004:2333–8 Predicting Depression in Heart Failuref adverse outcomes. Future studies are warranted to eval-
ate whether health status-guided management of patients
ith HF can improve outcomes.
The reasons for the elevated incidence of depression in
atients with HF are uncertain, but genetic (28), physio-
ogic, and psychodynamic factors have all been postulated as
ontributors. With regard to genetic factors, recent studies
ave identified the same genetic polymorphisms to be
ssociated with the development of both depression and
ardiovascular disease (29). The G-protein beta-3 825T
llele has been associated with depression (28,30) and also
ith hypertension (31), an important risk factor for HF
32,33). A gene-gene interaction between the G-protein
eta-3 825T allele and the angiotensin-converting enzyme
allele (34) has also been implicated in the genesis of both
llnesses, and gene-environment interactions have been
dentified (35). With regard to physiologic factors, increased
evels of circulating catecholamines are observed in both
llnesses (36,37), and high levels of catecholamines resulting
rom HF might potentiate depression. Furthermore, pa-
ients with HF have elevated levels of cytokines, some of
hich (particularly interleukin-2) have been shown to cause
epressive symptoms (38). Finally, with regard to psychody-
amic factors, stressful life events have been demonstrated
o precipitate depression (39), and the threat of death and
oss of autonomy that accompany HF are consistent with
nown depression-generating stressors. Our study, although
ot addressing the contributions of genetic and physiologic
actors, demonstrates that environmental factors in the
ocial milieu significantly contribute to the onset of depres-
ion in HF.
The current study has several limitations. First, we did
ot attempt to establish a diagnosis of major depressive
isorder through use of a structured interview based on
riteria from the American Psychiatric Association’s Diag-
ostic and Statistical Manual of Mental Disorders. However,
he validity of the MOS-D as a case-finding instrument in
tudies of depression is well established (13), and multiple
tudies have demonstrated the importance of depressive
ymptoms as predictors of outcome in patients with HF
6–8). Second, our sample was relatively small, limiting the
umber of variables we could reasonably examine by mul-
ivariable analysis. This is unlikely, however, to invalidate
he significant predictors that we found. Finally, this study
able 3. Results of Multivariable Logistic Regression Model of
redictors of Depressive Symptoms at One Year Adjusting for
aseline MOS-D Score
Variable Odds Ratio 95% CI p Value
iving alone 2.81 1.33–5.99 0.007
conomic burden 2.92 1.45–6.01 0.003
lcohol abuse 3.02 1.23–7.24 0.014
CCQ overall score
(per 10 points lower score)
1.22 1.04–1.43 0.015
OS-D  Medical Outcomes Study-Depression questionnaire; other abbreviations
s in Table 2.nrolled a convenience sample of outpatients with HF,
1hich could limit generalizability. However, one would
xpect fewer patients with social risk factors (living alone,
lcohol abuse, etc.) to participate in such a study; therefore,
e may have underestimated the associations found.
In conclusion, readily measured patient characteristics
an identify HF patients at high risk for the development of
epressive symptoms. Future studies are needed to evaluate
hether interventions aimed at the prevention of depression
nd/or the treatment of depression in those who screen
ositive will improve outcomes. In the meantime, clinicians
hould be aware of the high incidence of depressive symp-
oms and the risk factors for development of depression in
atients with HF.
eprint requests and correspondence: Dr. Edward P. Havranek,
enver Health Medical Center #0960, 777 Bannock Street,
enver, Colorado 80204-4507. E-mail: ehavrane@dhha.org.
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